Related Experiment Video
Updated: Apr 20, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Clinical transplantation and tolerance: are we there yet?
R F Saidi1, S K Hejazii Kenari1
1Division of Organ Transplantation, Department of Surgery, Alpert Medical School of Brown University, Providence, RI, USA.
Organ transplantation saves lives but requires lifelong immunosuppression to prevent rejection. Minimizing or withdrawing these drugs can improve long-term outcomes and quality of life, especially for children.
Area of Science:
- Immunology
- Transplantation Medicine
- Pediatric Nephrology
Background:
- Organ transplantation is a critical treatment for end-stage organ damage.
- Immune response poses a significant challenge to transplant success.
- Current methods rely on broad immunosuppression, leading to adverse effects.
Purpose of the Study:
- To highlight the challenges of immunosuppression in organ transplantation.
- To emphasize the need for strategies to reduce or eliminate immunosuppression.
- To improve the quality of life and long-term outcomes for pediatric transplant recipients.
Main Methods:
- Review of current immunosuppression protocols.
- Analysis of long-term side effects of immunosuppressive therapy.
- Exploration of strategies to minimize immunosuppression.
Main Results:
- Lifelong immunosuppression causes significant side effects including infections, malignancies, and chronic diseases.
- Pediatric recipients face prolonged exposure to these risks due to longer life expectancy.
- Reducing immunosuppression is crucial for better patient outcomes.
Conclusions:
- Minimizing or withdrawing immunosuppression is essential for improving patient quality of life.
- This approach is particularly vital for pediatric transplant recipients.
- Further research into novel immunosuppression-minimizing strategies is warranted.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant I: Introduction
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Kidney Transplant II: Surgical Procedure

